⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9419892 | 0.72 | — | — | |
| SCHEMBL17816400 | 0.70 | — | — | |
| SCHEMBL7216267 | 0.70 | — | — | |
| SCHEMBL9147924 | 0.70 | — | — | |
| SCHEMBL17816397 | 0.70 | — | — | |
| SCHEMBL1268596 | 0.69 | — | — | |
| SCHEMBL468058 | 0.69 | TSHR (0.37) | — | |
| SCHEMBL23778536 | 0.67 | — | — | |
| SCHEMBL19485348 | 0.67 | — | — | |
| SCHEMBL17816405 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11542232-B2 | Process for production of glycopyrronium tosylate | JOURNEY MEDICAL CORPORATION (US) | 2023-01-03 | — | — | US | disclosed |
| EP-3494106-B1 | PROCESSES FOR MAKING, AND METHODS OF USING, GLYCOPYRRONIUM COMPOUNDS | JOURNEY MEDICAL CORP (US) | 2022-07-20 | — | — | EP | disclosed |
| US-11352323-B2 | Processes for making, and methods of using, glycopyrronium compounds | JOURNEY MEDICAL CORPORATION (US) | 2022-06-07 | — | — | US | disclosed |
| US-20210130289-A1 | PROCESSES FOR MAKING, AND METHODS OF USING, GLYCOPYRRONIUM COMPOUNDS | SWK FUNDING LLC | 2021-05-06 | — | — | US | disclosed |
| US-10906871-B2 | Processes for making, and methods of using, glycopyrronium compounds | DERMIRA, INC. (US) | 2021-02-02 | — | — | US | disclosed |
| US-20210002219-A1 | PROCESS FOR PRODUCTION OF GLYCOPYRRONIUM TOSYLATE | SWK FUNDING LLC | 2021-01-07 | — | — | US | disclosed |
| CN-111840294-A | Method for improving resistance to skeletal muscle fatigue | 赛特凯恩蒂克公司 | 2020-10-30 | — | — | CN | disclosed |
| CN-110730782-A | Photodynamic therapy compounds and methods of photodynamic therapy | 光盐生物科技有限公司 | 2020-01-24 | — | — | CN | disclosed |
| US-20190225580-A1 | PROCESS FOR PRODUCTION OF GLYCOPYRRONIUM TOSYLATE | DERMIRA, INC. | 2019-07-25 | — | — | US | disclosed |
| US-20190161443-A1 | PROCESSES FOR MAKING, AND METHODS OF USING, GLYCOPYRRONIUM COMPOUNDS | SWK FUNDING LLC | 2019-05-30 | — | — | US | disclosed |
| US-10294201-B2 | Process for production of glycopyrronium tosylate | DERMIRA, INC. (US) | 2019-05-21 | — | — | US | disclosed |
| US-20180186735-A1 | PROCESS FOR PRODUCTION OF GLYCOPYRRONIUM TOSYLATE | SWK FUNDING LLC | 2018-07-05 | — | — | US | disclosed |
| US-9926270-B2 | Process for production of glycopyrronium tosylate | DERMIRA, INC. (US) | 2018-03-27 | — | — | US | disclosed |
| US-20160052879-A1 | PROCESS FOR PRODUCTION OF GLYCOPYRRONIUM TOSYLATE | SWK FUNDING LLC | 2016-02-25 | — | — | US | disclosed |
| US-20070190523-A1 | Method and compositions for identifying anti-hiv therapeutic compounds | GILEAD SCIENCES, INC. | 2007-08-16 | — | — | US | disclosed |
| EP-0911374-B1 | WATER BASE INK SET FOR INK JET RECORDING | SEIKO EPSON CORP (JP) | 2004-11-17 | — | — | EP | disclosed |
| US-6211265-B1 | INKS WITH BLACK, YELLOW, CYAN AND MAGENTA COLORS WITH CATIONIC POLYMERS | SEIKO EPSON CORPORATION (JP) | 2001-04-03 | — | — | US | disclosed |
| EP-0911374-A1 | WATER BASE INK SET FOR INK JET RECORDING | SEIKO EPSON CORPORATION (JP) | 1999-04-28 | — | — | EP | disclosed |